NasdaqGM:PRCTMedical Equipment
Assessing PROCEPT BioRobotics (PRCT) Valuation After HYDROS Robotic System Expansion News
HYDROS expansion puts PROCEPT BioRobotics in focus
PROCEPT BioRobotics (PRCT) is drawing attention after announcing the international expansion of its HYDROS Robotic System, an AI-enabled Aquablation platform for treating benign prostatic hyperplasia, with the rollout starting in the UK.
See our latest analysis for PROCEPT BioRobotics.
The HYDROS rollout news comes after a busy spell for PROCEPT BioRobotics, including the recent board appointment of former Shockwave Medical CFO Daniel...